Clinical trial

Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?

Name
07302018.031
Description
In summary, the investigators propose to study elite Croatian breath-hold and SCUBA divers. The investigators will quantify breath-hold hypoxia- and SCUBA diving-induced pulmonary hypertension and right heart function to investigate the relationships between PFO and IPAVA blood flow. The investigators will use a placebo-controlled intervention (sildenafil) to reduce pulmonary arterial pressure in these subjects to examine the impact of the change in pressure (or absence of change) on the relationships determined above.
Trial arms
Trial start
2019-07-01
Estimated PCD
2023-01-31
Trial end
2023-07-31
Status
Completed
Phase
Early phase I
Treatment
Sildenafil
50mg administration of sildenafil, one time, one hour prior to measurements.
Arms:
Sildenafil administration
Placebo
50mg administration in gel-encapsulated microcrystalline cellulose one time, one hour prior to measurements.
Arms:
Placebo administration
Size
82
Primary endpoint
Pulmonary Pressure
1 hour post intervention
Concentration of Myoglobin
1 hour post intervention
Concentration of MRP8/14
1 hour post intervention
Concentration of NGAL
1 hour post intervention
Concentration Of CRP
1 hour post intervention
Concentration Of MMP-2
1 hour post intervention
Concentration of OPN
1 hour post intervention
Concentration Of SAA
1 hour post intervention
Concentration of IGFBP-4
1 hour post intervention
Concentration of ICAM-1
1 hour post intervention
Concentration of VCAM-1
1 hour post intervention
Concentration of MMP-9
1 hour post intervention
Concentration of Cystatin C
1 hour post intervention
Change in Q-IPAVA
1 hour post intervention
Eligibility criteria
Inclusion Criteria: * Reside in geographic location near Split, Croatia * Elite breath hold divers * Experienced SCUBA divers Exclusion Criteria: * Previous history of coronary artery disease * Currently taking medication or herbal supplement for any heart or respiratory disease that cannot be ceased for 48 hours prior to testing * Women who are pregnant or trying to become pregnant * Previous history of any condition that would prevent the subject from performing a breath hold * Taking sildenafil or products similar to sildenafil * Taking Nitrates or other nitric oxide donors * Control breath hold divers can't have previous breath hold diving experience
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'CROSSOVER', 'interventionModelDescription': 'Breath hold divers will be administered sildenafil and placebo. Age-matched controls will be administered sildenafil and placebo.', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'Utilization of placebo to mask drug administration.', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 82, 'type': 'ACTUAL'}}
Updated at
2023-08-14

1 organization

1 product

2 indications

Product
Sildenafil